$PAHC News

Citigroup Maintains Neutral on Phibro Animal Health, Lowers Price Target to $44

Phibro Animal Health Corporation (PAHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Phibro Animal Health Corporation 2026 Q3 - Results - Earnings Call Presentation

Phibro Animal Health Corporation (PAHC) Q3 2026 Earnings Call Transcript

Phibro Animal Health (NASDAQ:PAHC) Beats Q3 Estimates, But Stock Slides on Brazil Regulatory Uncertainty

Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.93-$3.10 to $2.98-$3.10 vs $3.03 Est; Raises FY2026 Sales Guidance from $1.45B-$1.50B to $1.46B-$1.50B vs $1.488B Est

Phibro Animal Health Corporation Announces Expected Implementation Of New Regulatory Framework Governing The Use Of Certain Antimicrobials In Brazil

Citigroup Initiates Coverage On Phibro Animal Health with Neutral Rating, Announces Price Target of $62

Zacks Investment Ideas feature highlights Phibro, Deluxe, Remitly and BrightSpring

Phibro Animal Health Corp-A (NASDAQ:PAHC) Passes Minervini's High-Growth Momentum Screen

Phibro Animal Health Corporation (PAHC) Presents at BofA Securities Animal Health Summit Transcript

Why Phibro (PAHC) International Revenue Trends Deserve Your Attention

Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

3 Reasons Growth Investors Will Love Phibro (PAHC)

Phibro Animal Health Corporation (PAHC) Hit a 52 Week High, Can the Run Continue?

Phibro Animal Health Q2 Earnings Call Highlights

Phibro Animal Health (PAHC) Is Up 25.3% After Issuing 2026 Sales And EPS Guidance - What's Changed

Phibro Animal Health Corp (PAHC) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ...

Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call Transcript

Phibro Animal Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.